Videos

A global consensus just renamed PCOS to PMOS. Our experts explain why the shift moves care beyond the ovaries — and what it means for how clinicians talk to patients today.

In "Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain," the panel reviews two-year outcomes from a major open-label extension trial.

Recognizing hypercortisolism is only the first step. Expert faculty discuss how thoughtful evaluation, strong clinical advocacy, and coordinated referral can help patients receive timely diagnosis and appropriate care.

In "Choosing Between Newer GnRH Antagonist Therapies for Endometriosis," Dr. Davitt compares two newer, FDA-approved options for treating endometriosis-associated pain.

Expert faculty examine how resistant hypertension may signal underlying hypercortisolism and discuss when clinicians should think beyond routine blood pressure management.

Once-weekly insulin's longer half-life reshapes the hypoglycemia conversation, and trial data point to a bigger role for CGM in primary care.

New research links cardiovascular-kidney-metabolic health stage to measurable arterial injury in adults as young as 23, with obesity the leading driver.

Josef Coresh, MD, discusses biomarkers, hearing correction, and integrated vascular care as emerging dementia prevention strategies.

In "Comparing GnRH Agonists and Antagonists for Endometriosis Pain," Dr. Davitt explains the mechanistic split between two major drug classes used to manage endometriosis pain.

Expert faculty discuss how treatment outcomes and emerging evidence strengthen the case for earlier recognition of hypercortisolism in primary care.

Expert faculty demonstrate how practical hypercortisolism screening can be in primary care when clinicians know which test to use and how to use it.

In "Why Estrogen Suppression Anchors Endometriosis Treatment," the panel explores the biological rationale that makes estrogen suppression the backbone of medical therapy.

A nurse practitioner discusses why once-weekly basal insulin matters, who benefits most, and how its starting doses differ from daily insulin.

Josef Coresh, MD, PhD, discusses how primary care clinicians can address hypertension, diabetes, and smoking to support long-term cognitive health.

"Weighing Surgical Versus Medical Management in Endometriosis" takes up the question of when a patient's endometriosis care should shift from medicine to the operating room.

The panel of experts examines how the CATALYST trial is changing the way primary care clinicians recognize hypercortisolism in patients with difficult-to-control type 2 diabetes.

Patients who keep missing treatment goals despite good therapy may be facing an unrecognized hormonal driver that primary care is now positioned to catch early.

In "Understanding the Different Types of Endometriosis Lesions," our experts turn to the primary goals of treatment and the disease's four distinct subtypes.

Corresponding author Josef Coresh, MD, PhD, explains how hypertension, diabetes, and smoking in midlife were linked to fewer dementia-free survival years.

In "ACOG's New Guidance on Diagnosing Endometriosis Without Surgery," Dr. Davitt reflects on what ACOG's March 2026 guideline update means in daily practice.

In "Why Endometriosis Diagnosis Is Often Delayed by a Decade," the panel unpacks the factors behind a diagnostic delay that can stretch a decade.

Prebiotic sodas contain less sugar than regular soda and fruit drinks, but a new analysis finds they still lag diet soda and sparkling water on sugar content.

A Harvard-led analysis of more than 200,000 US adults found healthy plant-based diets lowered cardiometabolic risk regardless of ultra-processed food content.

Identifying who is most at risk for endometriosis, and recognizing its hallmark symptoms early, can shorten the path to diagnosis and reduce its enormous economic toll.

Endometriosis affects far more women than commonly cited figures suggest, and the gap between perception and reality shapes how the disease is diagnosed and treated.

Primary care faces a colorectal cancer screening backlog. Mark Fendrick, MD, describes noninvasive testing and mandatory colonoscopy follow-up.

Ruth Benca, MD, PhD, and Adam Spira, PhD, discuss how sleep disturbances, especially sleep apnea, may drive dementia risk and what to ask patients.

SLEEP 2026: A sleep expert discusses screening tools, referral pathways, and why sleep disorders matter for cardiometabolic health in primary care.

Tirzepatide, nerve stimulation, and oral AD109 are reshaping OSA care as phenotyping replaces the one-size-fits-all CPAP default.

Sairam Parthasarathy, MD, discusses late-breaking research he presented at SLEEP 2026 that showed hypoglossal nerve stimulation outperformed CPAP to improve OSA.